Dermatitis due to transdermal therapeutic systems.
D000287:Administration, Topical; D003875:Drug Eruptions / Q000209:etiology*; D006801:Humans; D005996:Nitroglycerin / Q000008:administration & dosage / Q000009:adverse effects*; D012306:Risk; D012601:Scopolamine / Q000008:administration & dosage / Q000009:adverse effects*
D012601:Scopolamine; D005996:Nitroglycerin